|
000
| 01259nam##2200253za#4500 |
|---|
| 001 | 9.579629 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210624190643 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 150406|2014||||xxc|||||o f|0| 0 eng|d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aXC62-1/1-412-2E-PDF |
|---|
| 110 | 1 |aCanada. |bParliament. |bHouse of Commons. |bStanding Committee on Health. |
|---|
| 245 | 10|aGovernment's role in addressing prescription drug abuse / |h[electronic resource]|cBen Lobb, Chair. |
|---|
| 260 | |aOttawa - Ontario : |bHouse of Commons. |cApril 2014. |
|---|
| 300 | |a64p. |
|---|
| 490 | 1 |aReport of the Standing Committee on Health|v2nd report, 41st Parliament, 2nd session |
|---|
| 500 | |aOriginal published on: 2014/04/10; published on: 2014/04/24; published on: 2014/04/29. |
|---|
| 590 | |a14-16|b2014-04-17 |
|---|
| 590 | |a14-18|b2014-05-02 |
|---|
| 775 | 08|tRôle du gouvernement dans la lutte contre l'abus de médicaments d'ordonnance / |w(CaOODSP)9.606982 |
|---|
| 830 | #0|aReport of the Standing Committee on Health ;|v2nd report, 41st Parliament, 2nd session|w(CaOODSP)9.507061 |
|---|
| 856 | 40|ahttp://publications.gc.ca|qPDF|s606 KB|uhttps://publications.gc.ca/collections/collection_2014/parl/xc62-1/XC62-1-1-412-2-eng.pdf|y2nd report, 41st Parliament, 2nd session |
|---|